Cargando…
Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study
OBJECTIVES: Broad international guidelines and studies in the context of individual clinical trials highlight the centrality of community stakeholder engagement in conducting ethically rigorous HIV prevention trials. We explored and identified challenges and facilitators for community stakeholder en...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546590/ https://www.ncbi.nlm.nih.gov/pubmed/26295159 http://dx.doi.org/10.1371/journal.pone.0135937 |
_version_ | 1782386949187698688 |
---|---|
author | Newman, Peter A. Rubincam, Clara Slack, Catherine Essack, Zaynab Chakrapani, Venkatesan Chuang, Deng-Min Tepjan, Suchon Shunmugam, Murali Roungprakhon, Surachet Logie, Carmen Koen, Jennifer Lindegger, Graham |
author_facet | Newman, Peter A. Rubincam, Clara Slack, Catherine Essack, Zaynab Chakrapani, Venkatesan Chuang, Deng-Min Tepjan, Suchon Shunmugam, Murali Roungprakhon, Surachet Logie, Carmen Koen, Jennifer Lindegger, Graham |
author_sort | Newman, Peter A. |
collection | PubMed |
description | OBJECTIVES: Broad international guidelines and studies in the context of individual clinical trials highlight the centrality of community stakeholder engagement in conducting ethically rigorous HIV prevention trials. We explored and identified challenges and facilitators for community stakeholder engagement in biomedical HIV prevention trials in diverse global settings. Our aim was to assess and deepen the empirical foundation for priorities included in the GPP guidelines and to highlight challenges in implementation that may merit further attention in subsequent GPP iterations. METHODS: From 2008–2012 we conducted an embedded, multiple case study centered in Thailand, India, South Africa and Canada. We conducted in-depth interviews and focus groups with respondents from different trial-related subsystems: civil society organization representatives, community advocates, service providers, clinical trialists/researchers, former trial participants, and key HIV risk populations. Interviews/focus groups were recorded, and coded using thematic content analysis. After intra-case analyses, we conducted cross-case analysis to contrast and synthesize themes and sub-themes across cases. Lastly, we applied the case study findings to explore and assess UNAIDS/AVAC GPP guidelines and the GPP Blueprint for Stakeholder Engagement. RESULTS: Across settings, we identified three cross-cutting themes as essential to community stakeholder engagement: trial literacy, including lexicon challenges and misconceptions that imperil sound communication; mistrust due to historical exploitation; and participatory processes: engaging early; considering the breadth of “community”; and, developing appropriate stakeholder roles. Site-specific challenges arose in resource-limited settings and settings where trials were halted. CONCLUSIONS: This multiple case study revealed common themes underlying community stakeholder engagement across four country settings that largely mirror GPP goals and the GPP Blueprint, as well as highlighting challenges in the implementation of important guidelines. GPP guidance documents could be strengthened through greater focus on: identifying and addressing the community-specific roots of mistrust and its impact on trial literacy activities; achieving and evaluating representativeness in community stakeholder groups; and addressing the impact of power and funding streams on meaningful engagement and independent decision-making. |
format | Online Article Text |
id | pubmed-4546590 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-45465902015-09-01 Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study Newman, Peter A. Rubincam, Clara Slack, Catherine Essack, Zaynab Chakrapani, Venkatesan Chuang, Deng-Min Tepjan, Suchon Shunmugam, Murali Roungprakhon, Surachet Logie, Carmen Koen, Jennifer Lindegger, Graham PLoS One Research Article OBJECTIVES: Broad international guidelines and studies in the context of individual clinical trials highlight the centrality of community stakeholder engagement in conducting ethically rigorous HIV prevention trials. We explored and identified challenges and facilitators for community stakeholder engagement in biomedical HIV prevention trials in diverse global settings. Our aim was to assess and deepen the empirical foundation for priorities included in the GPP guidelines and to highlight challenges in implementation that may merit further attention in subsequent GPP iterations. METHODS: From 2008–2012 we conducted an embedded, multiple case study centered in Thailand, India, South Africa and Canada. We conducted in-depth interviews and focus groups with respondents from different trial-related subsystems: civil society organization representatives, community advocates, service providers, clinical trialists/researchers, former trial participants, and key HIV risk populations. Interviews/focus groups were recorded, and coded using thematic content analysis. After intra-case analyses, we conducted cross-case analysis to contrast and synthesize themes and sub-themes across cases. Lastly, we applied the case study findings to explore and assess UNAIDS/AVAC GPP guidelines and the GPP Blueprint for Stakeholder Engagement. RESULTS: Across settings, we identified three cross-cutting themes as essential to community stakeholder engagement: trial literacy, including lexicon challenges and misconceptions that imperil sound communication; mistrust due to historical exploitation; and participatory processes: engaging early; considering the breadth of “community”; and, developing appropriate stakeholder roles. Site-specific challenges arose in resource-limited settings and settings where trials were halted. CONCLUSIONS: This multiple case study revealed common themes underlying community stakeholder engagement across four country settings that largely mirror GPP goals and the GPP Blueprint, as well as highlighting challenges in the implementation of important guidelines. GPP guidance documents could be strengthened through greater focus on: identifying and addressing the community-specific roots of mistrust and its impact on trial literacy activities; achieving and evaluating representativeness in community stakeholder groups; and addressing the impact of power and funding streams on meaningful engagement and independent decision-making. Public Library of Science 2015-08-21 /pmc/articles/PMC4546590/ /pubmed/26295159 http://dx.doi.org/10.1371/journal.pone.0135937 Text en © 2015 Newman et al http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. |
spellingShingle | Research Article Newman, Peter A. Rubincam, Clara Slack, Catherine Essack, Zaynab Chakrapani, Venkatesan Chuang, Deng-Min Tepjan, Suchon Shunmugam, Murali Roungprakhon, Surachet Logie, Carmen Koen, Jennifer Lindegger, Graham Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study |
title | Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study |
title_full | Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study |
title_fullStr | Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study |
title_full_unstemmed | Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study |
title_short | Towards a Science of Community Stakeholder Engagement in Biomedical HIV Prevention Trials: An Embedded Four-Country Case Study |
title_sort | towards a science of community stakeholder engagement in biomedical hiv prevention trials: an embedded four-country case study |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4546590/ https://www.ncbi.nlm.nih.gov/pubmed/26295159 http://dx.doi.org/10.1371/journal.pone.0135937 |
work_keys_str_mv | AT newmanpetera towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT rubincamclara towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT slackcatherine towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT essackzaynab towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT chakrapanivenkatesan towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT chuangdengmin towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT tepjansuchon towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT shunmugammurali towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT roungprakhonsurachet towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT logiecarmen towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT koenjennifer towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy AT lindeggergraham towardsascienceofcommunitystakeholderengagementinbiomedicalhivpreventiontrialsanembeddedfourcountrycasestudy |